Chrysin and its emerging role in cancer drug resistance

被引：20
作者：
Kasala, Eshvendar Reddy [1 ]
Bodduluru, Lakshmi Narendra [1 ]
Barua, Chandana C. [2 ]
Gogoi, Ranadeep [3 ]
机构：
[1] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Gauhati 781032, Assam, India
[2] Assam Agr Univ, Coll Vet Sci, Dept Pharmacol & Toxicol, Gauhati 781022, Assam, India
[3] Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Gauhati 781032, Assam, India
来源：
CHEMICO-BIOLOGICAL INTERACTIONS | 2015年 / 236卷
关键词：
Cisplatin; Chrysin; Apoptosis; Cancer therapy; Drug resistance; CELLS; FLAVONOIDS; CISPLATIN;
D O I：
10.1016/j.cbi.2015.04.017
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
This letter illustrates the significant chemosensitizing effects of chrysin to resistance cancer cells and refers to the article on "Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53" by Li et al., published in your journal recently. Recent studies have demonstrated that chrysin is able to sensitize or kill cancer cells which are resistant to chemotherapeutic drugs such as cisplatin, doxorubicin and adriamycin. Owing to its potential anti-cancer effects and devoid of toxicity to non-transformed cells, further research is required to completely explore its chemosensitizing effects in other cancers and also assess and evaluate its safety, before going for possible human application. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：7 / 8
页数：2
相关论文
共 50 条
[21]   Role of Midkine in Cancer Drug Resistance: Regulators of Its Expression and Its Molecular Targeting [J].
Saikia, Minakshi ;
Cheung, Nathan ;
Singh, Abhay Kumar ;
Kapoor, Vaishali .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
[22]   The role of galectin-3 in cancer drug resistance [J].
Fukumori, Tomoharu ;
Kanayama, Hiro-omi ;
Raz, Avraham .
DRUG RESISTANCE UPDATES, 2007, 10 (03) :101-108
[23]   The role of miR-34 in cancer drug resistance [J].
Naghizadeh, Sanaz ;
Mohammadi, Ali ;
Duijf, Pascal H. G. ;
Baradaran, Behzad ;
Safarzadeh, Elham ;
Cho, William Chi-Shing ;
Mansoori, Behzad .
JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (10) :6424-6440
[24]   Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin [J].
Talebi, Marjan ;
Talebi, Mohsen ;
Farkhondeh, Tahereh ;
Simal-Gandara, Jesus ;
Kopustinskiene, Dalia M. ;
Bernatoniene, Jurga ;
Samarghandian, Saeed .
CANCER CELL INTERNATIONAL, 2021, 21 (01)
[25]   Loss of Scribble Promotes Snail Translation through Translocation of HuR and Enhances Cancer Drug Resistance [J].
Zhou, Yi ;
Chang, Renxu ;
Ji, Weiwei ;
Wang, Na ;
Qi, Meiyan ;
Xu, Yi ;
Guo, Jingyu ;
Zhan, Lixing .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (01) :291-302
[26]   Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin [J].
Marjan Talebi ;
Mohsen Talebi ;
Tahereh Farkhondeh ;
Jesus Simal-Gandara ;
Dalia M. Kopustinskiene ;
Jurga Bernatoniene ;
Saeed Samarghandian .
Cancer Cell International, 21
[27]   The critical role of NLRP3 in drug resistance of cancers: Focus on the molecular mechanisms and possible therapeutics [J].
Kuriakose, Beena Briget ;
Zwamel, Ahmed Hussein ;
Mutar, Ayad Abdulrazzaq ;
Uthirapathy, Subasini ;
Bishoyi, Ashok Kumar ;
Naidu, K. Satyam ;
Hjazi, Ahmed ;
Nakash, Prashant ;
Arya, Renu ;
Almalki, Sami G. .
SEMINARS IN ONCOLOGY, 2025, 52 (01) :27-40
[28]   Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance [J].
Di Donato, Marzia ;
Medici, Nicola ;
Migliaccio, Antimo ;
Castoria, Gabriella ;
Giovannelli, Pia .
CANCERS, 2023, 15 (19)
[29]   Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance [J].
Yao, Yihan ;
Zhou, Yunxiang ;
Liu, Lihong ;
Xu, Yanyan ;
Chen, Qiang ;
Wang, Yali ;
Wu, Shijie ;
Deng, Yongchuan ;
Zhang, Jianmin ;
Shao, Anwen .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
[30]   The emerging role of circular RNAs in drug resistance of non-small cell lung cancer [J].
Yan, Tinghao ;
Tian, Xinchen ;
Liu, Fen ;
Liu, Qingbin ;
Sheng, Qing ;
Wu, Jianlin ;
Jiang, Shulong .
FRONTIERS IN ONCOLOGY, 2022, 12
12345